Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (apre una nuova finestra)

Ball AM, Winstead PS.

Fonte‎: Pharmacotherapy 2008;28(11):1383-90.

Indicizzato‎: PubMed 18956998

DOI‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (apre una nuova finestra)

Recombinant human erythropoietin in severe anaemia: issues of dosing and duration. (apre una nuova finestra)

Charles A, Purtill M, Napolitano LM.

Fonte‎: Anaesth Intensive Care 2006;34(6):793-6.

Indicizzato‎: PubMed 17183900

https://www.ncbi.nlm.nih.gov/pubmed/17183900 (apre una nuova finestra)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (apre una nuova finestra)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

Fonte‎: N Engl J Med. 2023 2;389(18):1649-59.

Indicizzato‎: PubMed 37913505

DOI‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (apre una nuova finestra)

Bloodless management of the anemic patient in the emergency department. (apre una nuova finestra)

Johnson-Arbor K, Verstraete R

Fonte‎: Ann Emerg Med 2022;79(1):48-57.

Indicizzato‎: PubMed 34353645

DOI‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (apre una nuova finestra)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (apre una nuova finestra)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

Fonte‎: J Trauma 2008;65(2):285-97.

Indicizzato‎: PubMed 18695463

DOI‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (apre una nuova finestra)

Erythropoiesis in multiply injured patients. (apre una nuova finestra)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

Fonte‎: J Trauma 2006;61(5):1285-91.

Indicizzato‎: PubMed 17099548

DOI‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (apre una nuova finestra)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (apre una nuova finestra)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

Fonte‎: Arch Surg 2012;147(3):251-5.

Indicizzato‎: PubMed 22430906

DOI‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (apre una nuova finestra)

Zeugen Jehovas und Schwerverletzung mit drohender Hämorrhagie. Wie komplex ist die Behandlung? [Jehovah's Witnesses and severe injury with impending hemorrhaging: how complex is the treatment?] [German, English abstract] (apre una nuova finestra)

Zeckey C, Vanin N, Neitzke G, Mommsen P, Bachmann S, Frink M, Wilhelmi M, Krettek C, Hildebrand F.

Fonte‎: Chirurg 2011;82(6):531-5.

Indicizzato‎: PubMed 21088815

DOI‎: 10.1007/s00104-010-1999-y

https://www.ncbi.nlm.nih.gov/pubmed/21088815 (apre una nuova finestra)